Polly A. Murphy

AVIR

Polly A. Murphy serves as director at Atea Pharmaceuticals, Inc. (AVIR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

4 trades

$202.1K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$202.1K

Companies Traded

AVIR, CELC

Active Period

Dec 2021 – May 2026

4 total trades

Most Recent

Buy AVIR

May 21, 2026 · $25.4K

Polly A. Murphy's Insider Trading at Atea Pharmaceuticals, Inc. (AVIR)

Buys

3 · $153.7K

Sells

0 · $0.00

Total Shares Bought

24,200

Total Shares Sold

AVIR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 21, 2026	Buy	6,100	$4.17	$25.4K	92,145
May 20, 2026	Buy	6,100	$4.17	$25.4K	92,145
Dec 20, 2021	Buy	12,000	$8.57	$102.8K	0

Polly A. Murphy's Insider Trading at Celcuity Inc. (CELC)

Buys

1 · $48.4K

Sells

0 · $0.00

Total Shares Bought

5,000

Total Shares Sold

CELC Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 22, 2022	Buy	5,000	$9.68	$48.4K	0

Related Insiders

Richard E Buller

Director

CELCSell · May 6, 2026

David Dalvey

Director

CELCSell · May 6, 2026

Wayne Foster

EVP, Chief Accounting Officer

AVIRSell · Jan 31, 2026

Janet MJ Hammond

Chief Development Officer

AVIRSell · Jan 31, 2026

Maria Arantxa Horga

Chief Medical Officer

AVIRSell · Jan 31, 2026

Jean-Pierre Sommadossi

President, CEO, and Chairman

AVIRSell · Jan 31, 2026

John Vavricka

Chief Commercial Officer

AVIRSell · Jan 31, 2026

Andrea Corcoran

See Remarks

AVIRSell · Jan 31, 2026

Explore More Insider Trading Data

AVIR Insider Trading Activity

View all insider trades at Atea Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity